Best TWAS P=8.5e-14 · Best GWAS P=5.1e-11 conditioned to 0.97
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Adipose Visceral Omentum | FES | 0.21 | 0.09 | lasso | 5 | 0.05 | 1.3e-03 | 6.6 | -6.8 | 1.4e-11 | -0.99 | 0.00 | 0.99 | FALSE |
2 | GTEx | Artery Tibial | FES | 0.16 | 0.04 | lasso | 5 | 0.05 | 4.8e-05 | 6.3 | -6.7 | 1.8e-11 | -0.89 | 0.01 | 0.99 | FALSE |
3 | GTEx | Cells Transformed fibroblasts | FES | 0.28 | 0.17 | enet | 21 | 0.20 | 2.8e-15 | 6.6 | -7.0 | 3.4e-12 | -0.92 | 0.00 | 1.00 | FALSE |
4 | GTEx | Lung | FES | 0.24 | 0.07 | lasso | 6 | 0.05 | 5.1e-05 | 6.3 | -7.0 | 3.1e-12 | -0.90 | 0.00 | 0.99 | FALSE |
5 | GTEx | Skin Sun Exposed Lower leg | FES | 0.09 | 0.04 | lasso | 5 | 0.04 | 1.4e-04 | 6.6 | -5.9 | 4.8e-09 | -0.91 | 0.00 | 0.98 | FALSE |
6 | GTEx | Thyroid | FES | 0.33 | 0.19 | lasso | 6 | 0.18 | 4.3e-14 | 6.4 | -6.4 | 1.2e-10 | -0.95 | 0.01 | 0.99 | FALSE |
7 | METSIM | Adipose | FES | 0.08 | 0.06 | lasso | 3 | 0.05 | 6.8e-08 | 6.3 | -6.5 | 8.2e-11 | -0.88 | 0.01 | 0.99 | FALSE |
8 | YFS | Blood | FES | 0.31 | 0.11 | enet | 77 | 0.22 | 1.2e-68 | 6.6 | -5.8 | 6.0e-09 | -0.61 | 0.00 | 1.00 | FALSE |
9 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | FES | 0.06 | 0.05 | blup | 46 | 0.06 | 1.9e-05 | 6.4 | -5.7 | 9.7e-09 | -0.74 | 0.01 | 0.98 | FALSE |
10 | The Cancer Genome Atlas | Breast Invasive Carcinoma | FES | 0.06 | 0.05 | blup | 46 | 0.07 | 7.4e-14 | 6.6 | -7.5 | 8.5e-14 | -0.88 | 0.00 | 1.00 | TRUE |
11 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | FES | 0.06 | 0.02 | blup | 46 | 0.02 | 2.4e-02 | 6.6 | -6.7 | 1.7e-11 | -0.81 | 0.01 | 0.85 | FALSE |
12 | The Cancer Genome Atlas | Colon Adenocarcinoma | FES | 0.08 | 0.07 | blup | 46 | 0.06 | 3.4e-04 | 6.1 | -6.6 | 4.1e-11 | -0.84 | 0.02 | 0.96 | FALSE |
13 | The Cancer Genome Atlas | Glioblastoma Multiforme | FES | 0.12 | 0.06 | enet | 6 | 0.06 | 5.7e-03 | 6.3 | -6.1 | 1.1e-09 | -0.80 | 0.01 | 0.86 | FALSE |
14 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | FES | 0.06 | 0.03 | blup | 46 | 0.05 | 5.6e-06 | 6.3 | -6.3 | 2.9e-10 | -0.78 | 0.01 | 0.99 | FALSE |
15 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | FES | 0.10 | 0.07 | enet | 5 | 0.05 | 2.8e-06 | 6.4 | -6.0 | 1.6e-09 | -0.70 | 0.01 | 0.99 | FALSE |
16 | The Cancer Genome Atlas | Lung Adenocarcinoma | FES | 0.05 | 0.04 | lasso | 2 | 0.04 | 2.2e-05 | 6.6 | -7.0 | 2.5e-12 | -0.95 | 0.00 | 1.00 | FALSE |
17 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | FES | 0.08 | 0.07 | enet | 7 | 0.08 | 4.2e-09 | 6.6 | -6.8 | 1.4e-11 | -0.93 | 0.00 | 1.00 | FALSE |
18 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | FES | 0.13 | 0.16 | lasso | 2 | 0.14 | 6.1e-10 | 6.6 | -6.6 | 3.5e-11 | -0.99 | 0.00 | 1.00 | FALSE |
19 | The Cancer Genome Atlas | Prostate Adenocarcinoma | FES | 0.12 | 0.09 | lasso | 5 | 0.08 | 4.1e-09 | 6.6 | -7.0 | 2.5e-12 | -0.95 | 0.00 | 1.00 | FALSE |
20 | The Cancer Genome Atlas | Stomach Adenocarcinoma | FES | 0.04 | 0.01 | blup | 46 | 0.02 | 1.7e-02 | 6.4 | -6.9 | 5.8e-12 | -0.75 | 0.01 | 0.60 | FALSE |
21 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | FES | 0.32 | 0.26 | lasso | 2 | 0.25 | 2.0e-09 | 6.3 | -6.4 | 1.7e-10 | -0.96 | 0.00 | 1.00 | FALSE |
22 | The Cancer Genome Atlas | Thyroid Carcinoma | FES | 0.30 | 0.30 | lasso | 7 | 0.32 | 1.3e-31 | 6.3 | -7.0 | 3.1e-12 | -0.95 | 0.00 | 1.00 | FALSE |